drugset / Trial / NCT03274102
Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With EPI Vaccines
Phase 4
Completed
780 enrolled
Sinovac Biotech Co., Ltd
Guangdong Center for Disease Prevention and Control · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to evaluate the safety and immunogenicity of concomitant administration of EV71 vaccine with recombinant hepatitis B vaccine/Group A meningococcal polysaccharide vaccine.
Timeline
- Start
- 2017-04-22
- Primary completion
- 2017-11-01
- Completion
- 2017-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EV71 vaccine | Vaccine | 0.5 ml | Intramuscular |
| Subject | Group A meningococcal polysaccharide vaccine | Vaccine | 150 ug | Subcutaneous |
| Subject | recombinant hepatitis B vaccine | Vaccine | 0.5 ml | Intramuscular |